The FDA’s lack of concern ( see previous post ) about the safety of bisphenol A has now come under criticism from a subcommittee of its own science advisory board. As described in USA Today, the board criticizes the FDA for relying too heavily on industry-funded studies and not holding the studies to rigorous scientific standards. Here’s the board’s report.
The FDA’s lack of concern ( see previous post ) about the safety of bisphenol A has now come under criticism from a subcommittee of its own science advisory board. As described in USA Today, the board criticizes the FDA for relying too heavily on industry-funded studies and not holding the studies to rigorous scientific standards. Here’s the board’s report.